Zobrazeno 1 - 10
of 47
pro vyhledávání: '"C Arellano Serrano"'
Autor:
A McInerney, J Rodés-Cabau, G Veiga, D Lopez-Otero, E Muñoz-Garcia, F Campelo, JF Oteo, M Carnero, JD Tafur Soto, I Amat-Santos, A Travieso, S Mohammadi, M Barbanti, AN Cheema, S Toggweiler, F Saia, M Dabrowski, V Serra, F Alfonso, H Barbosa, A Regueiro, A Alperi, AG Ongay, JM Martinez Cereijo, AJ Muñoz-Garcia, A Matta, C Arellano-Serrano, A Barrero, G Tirado-Conte, N Gonzalo, XC Sanmartin, JM de la Torre Hernández, D Kalavrouziotis, L Maroto, A Forteza-Gil, J Cobiella, J Escaned, L Nombela-Franco
Publikováno v:
Oral abstract presentations 2.
Autor:
P Vela Martin, C Arellano Serrano, V Castro Urda, D Garcia Rodriguez, F Hernandez Terciado, E Garcia-Izquierdo, D De Castro Campos, D Jimenez Sanchez, A Matutano Munoz, J Toquero Ramos, A Garcia-Touchard, I Fernandez Lozano, J Goicolea Ruigomez, J Segovia-Cubero, J F Oteo Dominguez
Publikováno v:
European Heart Journal. 43
Introduction Permanent pacing is often needed in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) due to new onset conduction disorders. Nevertheless, continuous right ventricular pacing may deteriorate l
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Jimenez-Blanco Bravo, M. Gomez Bueno, C Arellano Serrano, L Perez Gomez, J. Segovia Cubero, M Torres Sanabria, F. Hernandez Perez
Publikováno v:
European Heart Journal. 42
Background Cardiac allograft vasculopathy (CAV) remains a major cause of morbidity and mortality among long-term heart transplant (HT) recipients. There is clearly an unmet need for a noninvasive biomarker of CAV that could obviate the need to perfor
Autor:
E Garcia Izquierdo Jaen, J.A. Fernandez Diaz, F. Dominguez Rodriguez, J. Segovia Cubero, J F Oteo Dominguez, F.J. Goicolea Ruigomez, A Garcia Touchard, C Arellano Serrano, C.S.A Salas Anton, Carlos Jorquera Aguilera, Y.S.A Sabater Altagracia, P. Garcia Pavia, M Del Trigo Espinosa
Publikováno v:
European Heart Journal. 42
Introduction Between the indications for endomyocardial biopsy (EMB) is the study of patients with heart failure associated with restrictive or infiltrative cardiomyopathy, such as cardiac amyloidosis if another workup is inconclusive. Although a ris
Autor:
M. Gomez Bueno, J Goicolea Ruigomez, C Arellano Serrano, C. Mitroi, A Garcia Touchard, F. Hernandez Perez, M Del Trigo Espinosa, J.A. Fernandez Diaz, J. Segovia Cubero, J F Oteo Dominguez
Publikováno v:
European Heart Journal. 42
Introduction Cardiac Allograft Vasculopathy (CAV) and Acute Rejection (AR) surveillance after a Heart Transplant (HT) is based on the performance of Coronary Angiography (CAG) that requires arterial access and Endomyocardial Biopsy, normally Ventricu
Autor:
J F Oteo Dominguez, C Arellano Serrano, J.A. Fernandez Diaz, J. Segovia Cubero, J Goicolea Ruigomez, Silvia Vilches-Soria, Arturo García-Touchard, M.A Caraballo Gomez, E. Leon Aliz, X Cia Mendioroz
Publikováno v:
European Heart Journal. 41
Background/Introduction Cardiac allograft vasculopathy (CAV) is a leading cause of morbidity and mortality of heart transplant recipients. Percutaneous coronary intervention (PCI) is an alternative to medical treatment, however long-term data from la
Autor:
C Arellano-Serrano, P Remior, Juan Francisco Oteo, S Garcia-Gomez, A Martinez Mingo, D Garcia-Rodriguez, Arturo García-Touchard, Susana Mingo, J.F Goicolea, F. Hernandez Perez, A Borrego, S Navarro, Eusebio García-Izquierdo, V Monivas Palomero
Publikováno v:
European Heart Journal. 41
Introduction Pulmonary hypertension (PH) is defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest, measured by right heart catheterization (RHC). Purpose To describe classical and myocardial deformation echocardiographic parameters in
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C Arellano Serrano, M Torres Sanabria, M. Jimenez-Blanco Bravo, M. Gomez Bueno, J. Segovia Cubero, F. Hernandez Perez, L Perez Gomez
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S40
Purpose To evaluate the performance of Donor-derived Cell Free DNA (ddcf-DNA) as a biomarker of cardiac allograft vasculopathy (CAV) in a cohort of heart transplant (HT) recipients undergoing routine coronary angiography. Methods We prospectively obt